Aldosterone Synthase Inhibitors and the Treatment of Essential Hypertension
Aldosterone Synthase Inhibitors and the Treatment of Essential Hypertension
About this item
Full title
Aldosterone Synthase Inhibitors and the Treatment of Essential Hypertension
Author / Creator
Publisher
US: Oxford University Press
Journal title
The journal of clinical endocrinology and metabolism, 2023-08, Vol.108 (8), p.e638-e639
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Key Words: treatment-resistant hypertension, primary aldosteronism, aldosterone synthase inhibitors, Baxdrostat, mineralocorticoid receptor antagonists, Pathway-2
Alternative Titles
Full title
Aldosterone Synthase Inhibitors and the Treatment of Essential Hypertension
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10348457
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10348457
Other Identifiers
ISSN
0021-972X,1945-7197
E-ISSN
1945-7197
DOI
10.1210/clinem/dgad071
